CPIC guideline for serotonin reuptake inhibitors and CYP2D6, HTR2A and SLC6A4 - no recommendations 

This is a summary of the CPIC guideline for serotonin reuptake inhibitors and variation in the genes CYP2D6, CYP2C19, CYP2B6, HTR2A and SLC6A4.
This video will focus on the gene-drug pairs with no recommendations. Videos covering the gene-drug pairs with recommendations in this guideline can be found at the following links:
Citalopram, escitalopram and CYP2C19 - • CPIC guideline for cit...
Fluvoxamine and CYP2D6 - • CPIC guideline for flu...
Paroxetine and CYP2D6 - • CPIC guideline for par...
Sertraline and CYP2C19, CYP2B6 - • CPIC guideline for ser...
Venlafaxine and CYP2D6 - • CPIC guideline for ven...
Vortioxetine and CYP2D6 - • CPIC guideline for vor...
Guideline and supplemental information - cpicpgx.org/gu...
Guideline annotation for duloxetine and CYP2D6 - www.pharmgkb.o...
Guideline annotation for fluoxetine and CYP2D6 - www.pharmgkb.o...
Guideline annotation for citalopram, escitalopram and HTR2A
www.pharmgkb.o...
Guideline annotation for desvenlafaxine, duloxetine, fluoxetine, fluvoxamine, levomilnacipran, milnacipran, paroxetine, sertraline, venlafaxine, vilazodone, vortioxetine and HTR2A - www.pharmgkb.o...
Guideline annotation for citalopram, desvenlafaxine, duloxetine, escitalopram, fluoxetine, fluvoxamine, levomilnacipran, milnacipran, paroxetine, sertraline, venlafaxine, vilazodone, vortioxetine and SLC6A4 - www.pharmgkb.o...